T-lymphoid progenitor-based immunotherapies: clinical perspectives for one and all
Cell Mol Immunol
.
2022 Dec;19(12):1435-1438.
doi: 10.1038/s41423-022-00927-5.
Epub 2022 Sep 30.
Authors
P Gaudeaux
1
2
,
R D Moirangthem
1
,
J Paillet
1
2
,
M Martin-Corredera
1
2
,
H Sadek
2
,
P Rault
2
,
A Joshi
1
,
J Zuber
1
,
T S Soheili
2
,
O Negre
2
,
I André
3
Affiliations
1
Laboratory of Human Lymphohematopoieisis, Imagine Institute, INSERM UMR 1163, Université Paris Cité, Paris, France.
2
Smart Immune, Paris, France.
3
Laboratory of Human Lymphohematopoieisis, Imagine Institute, INSERM UMR 1163, Université Paris Cité, Paris, France.
[email protected]
.
PMID:
36180781
PMCID:
PMC9709039
DOI:
10.1038/s41423-022-00927-5
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
B-Lymphocytes*
Cell Differentiation
Immunotherapy*